James Shou
Overview
Explore the profile of James Shou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phipps C, Whitney D, Shou J, Torres-Russotto D, Warren D
Brain Sci
. 2024 Mar;
14(3).
PMID: 38539608
Orthostatic tremor is a rare movement disorder characterized by a sensation of unsteadiness and leg tremor while standing. It has been hypothesized that the disorder is attributable to dysregulation of...
2.
Thompson R, Bhatti D, Hellman A, Doss S, Malgireddy K, Shou J, et al.
Tremor Other Hyperkinet Mov (N Y)
. 2020 Dec;
10:54.
PMID: 33362948
Background: The exact pathophysiology of primary Orthostatic Tremor (OT) is unknown. A central oscillator is assumed, and previous imaging studies show involvement of cerebellar pathways. However, the presence of ataxia...
3.
Sunil Bendi V, Matta A, Torres-Russotto D, Shou J
BMJ Case Rep
. 2018 Jun;
2018.
PMID: 29925556
Non-ketotic hyperglycaemia (NKH) is the most common metabolic cause of hemichorea-hemiballismus (HC-HB) and an often-reversible condition. A 68-year-old man presented to the emergency department with a severe hyperglycaemic episode and...
4.
Sunil Bendi V, Shou J, Joy S, Torres-Russotto D
Parkinsonism Relat Disord
. 2018 Feb;
50:126-127.
PMID: 29467094
No abstract available.
5.
Krause M, Shou J, Joy S, Torres-Russotto D
Parkinsonism Relat Disord
. 2017 Apr;
39:91-92.
PMID: 28372974
No abstract available.
6.
Bennett C, Tomlinson C, Michalowski A, Chu I, Luger D, Mittereder L, et al.
Breast Cancer Res
. 2012 Jul;
14(4):R109.
PMID: 22812567
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is diagnosed in approximately 15% of all human breast cancer (BrCa) patients. Currently, no targeted therapies exist...